Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Heron Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 189
- −4 vs. Q1 2021
- Shares held
- 103.9M
- +12.7M (+14.0%) vs. Q1 2021
- Total value
- $1.61B
- +$129.5M (+8.7%) vs. Q1 2021
- New holders
- 35
- 65 more added
- Sold out
- 39
- 48 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 163 | $57.1M |
| Q1 2026 | 167 | $125.6M |
| Q4 2025 | 170 | $203.2M |
| Q3 2025 | 172 | $192.4M |
| Q2 2025 | 171 | $272.1M |
| Q1 2025 | 165 | $274.5M |
| Q4 2024 | 161 | $175.8M |
| Q3 2024 | 173 | $242.4M |
| Q2 2024 | 190 | $453.7M |
| Q1 2024 | 161 | $330.5M |
| Q4 2023 | 151 | $191.2M |
| Q3 2023 | 141 | $121.9M |
| Q2 2023 | 149 | $114.7M |
| Q1 2023 | 162 | $163.1M |
| Q4 2022 | 176 | $289.5M |
| Q3 2022 | 186 | $514.2M |
| Q2 2022 | 174 | $321.6M |
| Q1 2022 | 186 | $620.5M |
| Q4 2021 | 200 | $1.07B |
| Q3 2021 | 197 | $1.16B |
| Q2 2021 | 189 | $1.61B |
| Q1 2021 | 193 | $1.48B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Heron Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −51,690−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −47,100−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −45,788−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −37,000−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −36,028−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −31,308−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −28,221−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −26,627−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −25,661−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −23,128−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −19,123−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −18,001−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −16,308−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −15,940−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,872−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −4,604−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,771−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −1,752−100.0% | Sold out |
| Ameritas Investment Company, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Valley Brook Capital Group | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −915−100.0% | Sold out |
| Eudaimonia Partners, LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| IAG Wealth Partners, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −112−100.0% | Sold out |
| Filbrandt Wealth Management, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |